An Exploratory Clinical Study of Apatinib for the 2nd Treatment of Esophageal Cancer or Esophageal and Gastric

NCT03285906 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Esophagus Cancer, Stage III
Esophageal Gastric Cardia Type Metaplasia
Esophagus Cancer, Stage IV

Interventions

DRUG: Apatinib

Sponsor

Tianjin Medical University Cancer Institute and Hospital